Compounds > lopinavir
Page last updated: 2024-08-26

lopinavir and Embolism, Pulmonary

lopinavir has been researched along with Embolism, Pulmonary in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Airlangga, MP; Fatimah, FN; Miftahussurur, M; Pradana, AD; Rianda, RA; Rianda, RV; Subkhan, M1
Amini, H; Azhdari Tehrani, H; Haji Aghajani, M; Moradi, O; Pourheidar, E; Rabiei, MM; Sistanizad, M1
Beytout, J; Bocquier, B; Cormerais, L; Jacomet, C; Laurichesse, H; Lesens, O; Lyonne, L; Magimel, C; Trouillier, S; Zenut, M1

Other Studies

3 other study(ies) available for lopinavir and Embolism, Pulmonary

ArticleYear
The Challenging Anticoagulant Therapy in COVID19 Patient with Associated Coagulopathy.
    Acta medica Indonesiana, 2021, Volume: 53, Issue:3

    Topics: Adult; Antiviral Agents; Azithromycin; Clinical Deterioration; COVID-19; COVID-19 Drug Treatment; Dose-Response Relationship, Drug; Drug Monitoring; Factor Xa Inhibitors; Fibrin Fibrinogen Degradation Products; Fondaparinux; Hemorrhage; Humans; Inosine Pranobex; Lopinavir; Male; Pulmonary Embolism; SARS-CoV-2; Thrombophilia; Treatment Outcome

2021
Decreased in-hospital mortality associated with aspirin administration in hospitalized patients due to severe COVID-19.
    Journal of medical virology, 2021, Volume: 93, Issue:9

    Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Antiviral Agents; Aspirin; Blood Platelets; Coronary Artery Disease; COVID-19; COVID-19 Drug Treatment; Diabetes Mellitus; Disseminated Intravascular Coagulation; Drug Combinations; Female; Hospital Mortality; Humans; Hypertension; Iran; Lopinavir; Lung; Male; Middle Aged; Platelet Aggregation Inhibitors; Pulmonary Embolism; Respiration, Artificial; Retrospective Studies; Ritonavir; SARS-CoV-2; Severity of Illness Index; Survival Analysis; Treatment Outcome

2021
[Thromboembolic events at the time of highly active antiretroviral therapies against human immunodeficiency virus].
    La Revue de medecine interne, 2008, Volume: 29, Issue:2

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Female; Follow-Up Studies; France; HIV Protease Inhibitors; HIV Seropositivity; Humans; Lopinavir; Male; Middle Aged; Pulmonary Embolism; Pyrimidinones; Retrospective Studies; Ritonavir; Venous Thrombosis

2008